Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To review the literature on the association between antidiabetic agents and morbidity and mortality in people with heart failure and diabetes. DESIGN: Systematic review and meta-analysis of controlled studies (randomised trials or cohort studies) evaluating antidiabetic agents and outcomes (death and admission to hospital) in patients with heart failure and diabetes. DATA SOURCES: Electronic databases, manual reference search, and contact with investigators. REVIEW METHODS: Two reviewers independently extracted data. Risk estimates for specific treatments were abstracted and pooled estimates derived by meta-analysis where appropriate. RESULTS: Eight studies were included. Three of four studies found that insulin use was associated with increased risk for all cause mortality (odds ratio 1.25, 95% confidence interval 1.03 to 1.51; 3.42, 1.40 to 8.37 in studies that did not adjust for diet and antidiabetic drugs; hazard ratio 1.66, 1.20 to 2.31; 0.96, 0.88 to 1.05 in the studies that did). Metformin was associated with significantly reduced all cause mortality in two studies (hazard ratio 0.86, 0.78 to 0.97) compared with other antidiabetic drugs and insulin; 0.70, 0.54 to 0.91 compared with sulfonylureas); a similar trend was seen in a third. Metformin was not associated with increased hospital admission for any cause or for heart failure specifically. In four studies, use of thiazolidinediones was associated with reduced all cause mortality (pooled odds ratio 0.83, 0.71 to 0.97, I2=52%, P=0.02). Thiazolidinediones were associated with increased risk of hospital admission for heart failure (pooled odds ratio 1.13 (1.04 to 1.22), I2=0%, P=0.004). The two studies of sulfonylureas had conflicting results, probably because of differences in comparator treatments. Important limitations were noted in all studies. CONCLUSION: Metformin was the only antidiabetic agent not associated with harm in patients with heart failure and diabetes. It was associated with reduced all cause mortality in two of the three studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Downs, S. H., & Black, N. (1998) · Journal of Epidemiology and Community Health · doi:10.1136/jech.52.6.377 · Cited by 8,252
Cochrane Handbook for Systematic Reviews of Interventions
Higgins, J. P. T., Green, S., & Ben Van Den, A. (2020) · International Coaching Psychology Review · doi:10.53841/bpsicpr.2020.15.2.123 · Cited by 5,670
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675 · cited 1×
“Recently, the US Food and Drug Administration has changed the package labels for thiazolidinediones to include a “black box” warning emphasising that these drugs may cause or exacerbate heart failure in certain patients. Furthermore, given the recent controversy over the use of thiazolidinediones and increased risk of…”
BackgroundDormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67528-9 · Cited by 4,129
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
Role of diabetes in congestive heart failure: The Framingham study
Kannel, W. B., Hjortland, M., & Castelli, W. P. (1974) · The American Journal of Cardiology · doi:10.1016/0002-9149(74)90089-7 · Cited by 2,090
Pfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., Östergren, J., & Yusuf, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14282-1 · Cited by 1,889
The American Society of Health System Pharmacists
Beard, E. L. (2001) · JONA's Healthcare Law, Ethics, and Regulation · doi:10.1097/00128488-200109000-00003 · Cited by 1,678
McEvoy, G. K. (1994) · Oncology Issues · doi:10.1080/10463356.1994.11904493 · Cited by 888
The Incidence of Congestive Heart Failure in Type 2 Diabetes
Nichols, G. A., Gullion, C. M., Koro, C. E., Ephross, S. A., & Brown, J. B. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1879 · Cited by 812
Rosiglitazone Evaluated for Cardiovascular Outcomes — An Interim Analysis
Home, P. D., Pocock, S. J., Beck-Nielsen, H., Gomis, R., Hanefeld, M., Jones, N. P., Komajda, M., & McMurray, J. J. V. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073394 · Cited by 761
Glycemic Control and Heart Failure Among Adult Patients With Diabetes
Iribarren, C., Karter, A. J., Go, A. S., Ferrara, A., Liu, J. Y., Sidney, S., & Selby, J. V. (2001) · Circulation · doi:10.1161/01.cir.103.22.2668 · Cited by 710
Congestive Heart Failure in Type 2 Diabetes
Nichols, G. A., Hillier, T. A., Erbey, J. R., & Brown, J. B. (2001) · Diabetes Care · doi:10.2337/diacare.24.9.1614 · Cited by 600
Johnson, J. A., Majumdar, S. R., Simpson, S. H., & Toth, E. L. (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2244 · Cited by 421
Self-citationBell, D. S. H. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2433 · Cited by 404
Ezekowitz, J., McAlister, F. A., Humphries, K. H., Norris, C. M., Tonelli, M., Ghali, W. A., & Knudtson, M. L. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.06.072 · Cited by 377
Self-citationGarratt, K. N., Brady, P. A., Hassinger, N. L., Grill, D. E., Terzic, A., & Holmes, D. R. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00557-9 · Cited by 332
A Systematic Review and Meta-Analysis of Hypoglycemia and Cardiovascular Events
Gangji, A. S., Cukierman, T., Gerstein, H. C., Goldsmith, C. H., & Clase, C. M. (2007) · Diabetes Care · doi:10.2337/dc06-1789 · Cited by 308
Reis, S. E., Holubkov, R., Edmundowicz, D., McNamara, D. M., Zell, K. A., Detre, K. M., & Feldman, A. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00214-3 · Cited by 249
Simpson, S. H. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.050748 · Cited by 235 · cited 1×
“Given the current controversy surrounding the use of sulfonylureas in patients with pre-existing cardiovascular disease,”
BackgroundUse of Thiazolidinediones and Risk of Heart Failure in People With Type 2 Diabetes
Delea, T. E., Edelsberg, J. S., Hagiwara, M., Oster, G., & Phillips, L. S. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.2983 · Cited by 216
Held, C., Gerstein, H. C., Yusuf, S., Zhao, F., Hilbrich, L., Anderson, C., Sleight, P., & Teo, K. (2007) · Circulation · doi:10.1161/circulationaha.106.661405 · Cited by 202
Emslie‐Smith, A. M., Boyle, D. I. R., Evans, J. M. M., Sullivan, F., Morris, A. D., & for the DARTS/MEMO Collaboration (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00509.x · Cited by 194
Amato, L., Paolisso, G., Cacciatore, F., Ferrara, N., Ferrara, P., Canonico, S., Varricchio, M., & Rengo, F. (1997) · PubMed · Cited by 193
Impact of diabetes mellitus on long-term survival in patients with congestive heart failure
de Groote, P. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.01.010 · Cited by 192
Osteoporosis-Related Kyphosis and Impairments in Pulmonary Function: A Systematic Review
Harrison, R. A., Siminoski, K., Vethanayagam, D., & Majumdar, S. R. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061202 · Cited by 164
Self-citationA Systematic Review of Drug Therapy to Delay or Prevent Type 2 Diabetes
Padwal, R., Majumdar, S. R., Johnson, J. A., Varney, J., & McAlister, F. A. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.736 · Cited by 164
Self-citationThe PROactive study: some answers, many questions
Yki‐Järvinen, H. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67504-6 · Cited by 148
Eshaghian, S., Horwich, T. B., & Fonarow, G. C. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.10.008 · Cited by 145
Metformin and Thiazolidinedione Use in Medicare Patients With Heart Failure
Masoudi, F. A., Wang, Y., Inzucchi, S. E., Setaro, J. F., Havranek, E. P., Foody, J. M., & Krumholz, H. M. (2003) · JAMA · doi:10.1001/jama.290.1.81 · Cited by 133
Contra‐indications to metformin therapy are largely disregarded
Holstein, A., Nahrwold, D., Hinze, S., & Egberts, E. ‐. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00115.x · Cited by 132
The incidence of congestive heart failure associated with antidiabetic therapies
Nichols, G. A., Koro, C. E., Gullion, C. M., Ephross, S. A., & Brown, J. B. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.480 · Cited by 105
Should Physicians Address Patients' Spiritual Needs?
Catlin, E. A. (2002) · JAMA · doi:10.1001/jama.287.19.2502 · Cited by 102
Diabetes Mellitus and Heart Failure: Epidemiology, Mechanisms, and Pharmacotherapy
Masoudi, F. A., & Inzucchi, S. E. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.013 · Cited by 97
Pioglitazone initiation and subsequent hospitalization for congestive heart failure
Karter, A., Ahmed, A., Liu, J., Moffet, H. M., & Parker, M. M. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01704.x · Cited by 95
Maru, S., Koch, G. G., Stender, M., Clark, D., Gibowski, L., Petri, H., White, A. D., & Simpson, R. J. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.20 · Cited by 86
Frequency of Inappropriate Metformin Prescriptions
Horlen, C. K., Malone, R., Bryant, B., Dennis, B., Carey, T., Pignone, M., & Rothman, R. (2002) · JAMA · doi:10.1001/jama.287.19.2504-a · Cited by 76
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Gersh, B. J. (2008) · Yearbook of Cardiology · doi:10.1016/s0145-4145(08)04021-5 · Cited by 52
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
Leahy, J. L. (2007) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70285-2 · Cited by 40
Karter, A. J., Ahmed, A. T., Liu, J. Y., Moffet, H. H., Parker, M. M., Ferrara, A. M., & Selby, J. V. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.850-a · Cited by 36
Rosiglitazone evaluated for cardiovascular outcomes – an interim analysis
Bahtiyar, G., Jean‐Louis, G., Nessim, F., & McFarlane, S. I. (2007) · Therapy · doi:10.2217/14750708.4.5.507 · Cited by 27
Approach to the management of diabetic patients with heart failure: Role of thiazolidinediones
Fonarow, G. C. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.04.033 · Cited by 23
Majumdar, S. R., McAlister, F. A., Cree, M., Chang, W.-C., Packer, M., & Armstrong, P. W. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90069-0 · Cited by 21
Self-citationShould Physicians Address Patients' Spiritual Needs?
Catlin, E. A., & Todres, I. D. (2002) · JAMA · doi:10.1001/jama.287.19.2504 · Cited by 18
Dysglycemia and Heart Failure Hospitalization: What Is the Link?
Petrie, M. C., & McMurray, J. J. V. (2007) · Circulation · doi:10.1161/circulationaha.106.685214 · Cited by 10
Cited by
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8776 · Cited by 2,106
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,955
Metadata
- Authors
- Eurich, D. T., McAlister, F. A., Blackburn, D. F., Majumdar, S. R., Tsuyuki, R. T., Varney, J., & Johnson, J. A.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2007-08-30
- Volume
- 335
- Issue
- 7618
- Pages
- 497
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W1997759488
- Cited by
- 362
- References
- 50
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.